Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome
Makaleler > Tam Makale · 2011
Yazarlar: Baris Akinci, Aygül ÇELTİK, Faize YÜKSEL, Sinan Genc, Serkan Yener, Mustafa Secil, Mehmet Ali ÖZCAN, Sena Yesil
DIABETES RESEARCH AND CLINICAL PRACTICE, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2011, cilt 91, ss 26-31
DOI: 10.1016/j.diabres.2010.09.028
Özet
Osteoprotegerin (OPG), a novel soluble member of tumour necrosis factor receptor superfamily, has been shown to link cardiovascular disorders. The aim of this study is to investigate the potential relationship between serum OPG levels, cardiovascular risk factors and metabolic syndrome in a relatively large group of women with previous GDM.